✦ LIBER ✦

Predictive value of activated tyrosine kinase (Tyr1248) in patients with HER2-overexpressing metastatic breast cancer (MBC) treated with trastuzumab + chemotherapy regimens

✍ Scribed by R Giuliani; M Paesmans; V Durbecq; A Di Leo; D Larsimont; V Cocquyt; F Majois; C Sotiriou; M.J Piccart; F Cardoso

Book ID: 118622354
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 329 KB
Volume: 2
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(04)91006-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phosphorylated HER-2 tyrosine kinase and

Phosphorylated HER-2 tyrosine kinase and Her-2/neu gene amplification as predictive factors of response to trastuzumab in patients with HER-2 overexpressing metastatic breast cancer (MBC)

✍ Rosa Giuliani; Virginie Durbecq; Angelo Di Leo; Marianne Paesmans; Denis Larsimo 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 636 KB

412 POSTER High incidence of brain metas

412 POSTER High incidence of brain metastases in HER2-overexpressing metastatic breast cancer (MBC) patients (pts) treated with trastuzumab and chemotherapy

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 280 KB

Her-2/neu and EGFR tyrosine kinase activ

Her-2/neu and EGFR tyrosine kinase activation predict the efficacy of trastuzumab-based therapy in patients with metastatic breast cancer

✍ Gernot Hudelist; Wolfgang J. Köstler; Klaus Czerwenka; Ernst Kubista; Johannes A 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 372 KB 👁 2 views

## Abstract Her‐2/__neu__ overexpression in human breast cancer leads to an aggressive biological behavior and poor prognosis. Although the anti‐Her‐2/__neu__ antibody trastuzumab (Herceptin®) has become a valuable therapeutic option for patients with Her‐2/__neu__‐overexpressing breast cancer, man

Efficacy and tolerability of taxanes or

Efficacy and tolerability of taxanes or vinorelbine chemotherapy with trastuzumab as a first combination in Her-2 overexpressing patients with metastatic breast cancer

✍ I. Glogowska; Sienkiewicz-Kozlowska; E. Szombara; T. Pienkowski 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 274 KB

464 Efficacy and toxicity of docetaxel o

464 Efficacy and toxicity of docetaxel or cisplatin chemotherapy in combination with trastuzumab in the treatment of patients with chemotherapy pre-treated HER-2/neu overexpressed metastatic breast cancer

✍ B. Bauer-Kosinska; I. Lemanska; I. Glogowska; R. Sienkiewicz; T. Pienkowski 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 156 KB

2128 POSTER PTEN, EGFR, MAPK and Akt sta

2128 POSTER PTEN, EGFR, MAPK and Akt status by immunohistochemistry (IHC) in HER2-positive (HER2+) metastatic breast cancer (MBC) patients (pts) treated with trastuzumab (T) ± chemotherapy (CT): correlation with clinical outcome

✍ S. Gori; V. De Angelis; A. Sidoni; M. Colozza; I. Ferri; D. Fenocchio; V. Ludovi 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB